William Blair & Company
HAE icon

William Blair & Company’s Haemonetics HAE Stock Holding History

William Blair & Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-87,443
Closed -$3.68M – 2046
2013
Q4 		$3.68M Sell
87,443
-1,276,503
-94% -$52.5M 0.01% 998
2013
Q3 		$54.4M Sell
1,363,946
-1,151,990
-46% -$48.3M 0.1% 306
2013
Q2 		$104M Buy
+2,515,936
New +$102M 0.21% 138

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

William Blair & Company's HAE Position: Q1 2014 in Review

William Blair & Company sold out of Haemonetics (HAE) in Q1 2014, closing a stake of 87,443 shares — an estimated $3.68M sold.

William Blair & Company first reported a position in HAE in Q2 2013 and held it in 3 quarters. The position peaked at $104M in Q2 2013. 192 funds tracked by Wall St. Rank hold HAE as of Q1 2014.

  • William Blair & Company reported no remaining Haemonetics position as of Q1 2014 after selling out during the quarter.
  • William Blair & Company sold 87,443 Haemonetics shares in Q1 2014, an estimated $3.68M.
  • William Blair & Company first reported a position in Haemonetics in Q2 2013 and held it in 3 quarters.
  • William Blair & Company's Haemonetics position peaked at $104M in Q2 2013.
  • 192 funds tracked by Wall St. Rank held Haemonetics as of Q1 2014.

Based on William Blair & Company's 13F filing for Q1 2014, filed 6 May 2014.